LDLR and acute myeloid leukemia: Using a genome-wide CRISPR dropout screen, we identified genetic vulnerabilities, many involved in mitochondrial metabolism, including several genes (for example, SLC25A1, LDLR and HK3) whose expression correlates with worse AML patient survival.